Lannett Co Inc Net Profit Margin 2006-2019 | LCI

Lannett Co Inc net profit margin from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Lannett Co Inc Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-03-31 $0.69B $-0.28B -39.83%
2018-12-31 $0.69B $-0.27B -39.48%
2018-09-30 $0.68B $-0.27B -39.77%
2018-06-30 $0.68B $0.03B 4.24%
2018-03-31 $0.65B $0.05B 7.06%
2017-12-31 $0.64B $0.05B 7.50%
2017-09-30 $0.63B $0.04B 6.70%
2017-06-30 $0.63B $-0.00B 0.00%
2017-03-31 $0.66B $-0.00B -0.30%
2016-12-31 $0.64B $-0.02B -3.43%
2016-09-30 $0.60B $-0.02B -2.68%
2016-06-30 $0.54B $0.05B 8.49%
2016-03-31 $0.47B $0.08B 16.10%
2015-12-31 $0.43B $0.12B 27.15%
2015-09-30 $0.42B $0.15B 35.32%
2015-06-30 $0.41B $0.15B 36.95%
2015-03-31 $0.39B $0.14B 36.08%
2014-12-31 $0.37B $0.13B 34.42%
2014-09-30 $0.32B $0.10B 30.84%
2014-06-30 $0.27B $0.06B 21.17%
2014-03-31 $0.23B $0.04B 16.31%
2013-12-31 $0.19B $0.02B 9.90%
2013-09-30 $0.16B $0.01B 3.09%
2013-06-30 $0.15B $0.01B 9.27%
2013-03-31 $0.15B $0.01B 7.48%
2012-12-31 $0.14B $0.01B 6.47%
2012-09-30 $0.13B $0.01B 5.38%
2012-06-30 $0.12B $0.00B 3.23%
2012-03-31 $0.11B $0.00B 0.88%
2011-12-31 $0.11B $-0.00B -0.92%
2011-09-30 $0.11B 0 0.00%
2011-06-30 $0.11B 0 0.00%
2011-03-31 $0.12B $0.01B 4.35%
2010-12-31 $0.12B $0.01B 5.83%
2010-09-30 $0.12B $0.01B 4.20%
2010-06-30 $0.13B $0.01B 6.40%
2010-03-31 $0.13B $0.01B 5.56%
2009-12-31 $0.12B $0.01B 4.84%
2009-09-30 $0.12B $0.01B 6.45%
2009-06-30 $0.12B $0.01B 5.04%
2009-03-31 $0.11B $0.00B 3.81%
2008-12-31 $0.09B $0.00B 2.15%
2008-09-30 $0.08B $-0.00B -1.22%
2008-06-30 $0.07B $-0.00B -2.70%
2008-03-31 $0.07B $-0.01B -7.14%
2007-12-31 $0.07B $-0.01B -15.07%
2007-09-30 $0.08B $-0.01B -11.54%
2007-06-30 $0.08B $-0.01B -9.76%
2007-03-31 $0.08B $-0.00B -4.76%
2006-12-31 $0.08B $0.00B 5.00%
2006-09-30 $0.07B $0.00B 5.56%
2006-06-30 $0.06B $0.01B 7.81%
2006-03-31 $0.05B $-0.00B -3.70%
2005-12-31 $0.05B $-0.03B -69.57%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.223B $0.685B
Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $49.014B 31.32
Takeda Pharmaceutical (TAK) Japan $27.669B 8.12
Grifols (GRFS) Spain $12.383B 15.66
Ionis Pharmaceuticals (IONS) United States $9.082B 19.85
Sage Therapeutics (SAGE) United States $8.971B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.749B 10.62
Neurocrine Biosciences (NBIX) United States $7.293B 0.00
Catalent (CTLT) United States $6.736B 27.03
Nektar Therapeutics (NKTR) United States $5.890B 9.60
Tilray (TLRY) Canada $4.266B 0.00
United Therapeutics (UTHR) United States $3.833B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.702B 12.99
FibroGen (FGEN) United States $3.064B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.476B 8.91
PTC Therapeutics (PTCT) United States $2.306B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.279B 343.43
Portola Pharmaceuticals (PTLA) United States $2.073B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.858B 25.39
Xencor (XNCR) United States $1.851B 50.52
Tricida (TCDA) United States $1.841B 0.00
Aerie Pharmaceuticals (AERI) United States $1.831B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.789B 86.66
USANA Health Sciences (USNA) United States $1.725B 14.99
Ironwood Pharmaceuticals (IRWD) United States $1.713B 0.00
Zogenix (ZGNX) United States $1.645B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.517B 0.00
Heron Therapeutics (HRTX) United States $1.440B 0.00
Esperion Therapeutics (ESPR) United States $1.409B 0.00
Endo (ENDP) Ireland $1.346B 2.16
TURNING PT THER (TPTX) United States $1.215B 0.00
Corcept Therapeutics (CORT) United States $1.184B 16.90
Theravance Biopharma (TBPH) Cayman Islands $1.021B 0.00
Radius Health (RDUS) United States $0.973B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.889B 0.00
Aptorum Group (APM) China $0.826B 0.00
ArQule (ARQL) United States $0.823B 0.00
TherapeuticsMD (TXMD) United States $0.767B 0.00
ChemoCentryx (CCXI) United States $0.680B 0.00
ORGANOGENESIS (ORGO) United States $0.631B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.623B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.618B 0.00
Akebia Therapeutics (AKBA) United States $0.618B 0.00
CannTrust Holdings (CTST) Canada $0.604B 0.00
Odonate Therapeutics (ODT) United States $0.598B 0.00
Dermira (DERM) United States $0.534B 0.00
GlycoMimetics (GLYC) United States $0.506B 0.00
Flexion Therapeutics (FLXN) United States $0.484B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.471B 0.00
Translate Bio (TBIO) United States $0.468B 0.00
Siga Technologies (SIGA) United States $0.467B 1.10
BioSpecifics Technologies Corp (BSTC) United States $0.454B 22.92
KalVista Pharmaceuticals (KALV) United States $0.412B 0.00
Mast Therapeutics (SVRA) United States $0.405B 0.00
Collegium Pharmaceutical (COLL) United States $0.395B 0.00
Forty Seven (FTSV) United States $0.381B 0.00
Karyopharm Therapeutics (KPTI) United States $0.377B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.371B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.366B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.358B 0.00
TCR2 Therapeutics (TCRR) United States $0.334B 0.00
OptiNose (OPTN) United States $0.330B 0.00
Xeris Pharmaceuticals (XERS) United States $0.306B 0.00
CASI Pharmaceuticals (CASI) United States $0.302B 0.00
Molecular Templates (MTEM) United States $0.298B 0.00
ImmunoGen (IMGN) United States $0.298B 0.00
Harpoon Therapeutics (HARP) United States $0.285B 0.00
Dova Pharmaceuticals (DOVA) United States $0.280B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.266B 0.00
Concert Pharmaceuticals (CNCE) United States $0.262B 0.00
Aratana Therapeutics (PETX) United States $0.233B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.230B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.230B 0.00
Calithera Biosciences (CALA) United States $0.225B 0.00
MEI Pharma (MEIP) United States $0.222B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.221B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.216B 0.00
Aclaris Therapeutics (ACRS) United States $0.211B 0.00
Minerva Neurosciences (NERV) United States $0.210B 0.00
Recro Pharma (REPH) United States $0.208B 0.00
IMV INC (IMV) Canada $0.202B 0.00
Aldeyra Therapeutics (ALDX) United States $0.202B 0.00
Opexa Therapeutics (ACER) United States $0.189B 0.00
Nature's Sunshine Products (NATR) United States $0.185B 60.00
Galectin Therapeutics (GALT) United States $0.184B 0.00
Ardelyx (ARDX) United States $0.176B 0.00
Redhill Biopharma (RDHL) Israel $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.171B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.171B 0.00
Majesco Entertainment (PTE) United States $0.164B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.149B 0.00
Neon Therapeutics (NTGN) United States $0.148B 0.00
Tyme Technologies (TYME) United States $0.143B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Bio Blast Pharma (ENLV) Israel $0.120B 0.00
Champions Oncology (CSBR) United States $0.115B 0.00
Ocular Therapeutix (OCUL) United States $0.113B 0.00
MediWound (MDWD) Israel $0.112B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.109B 0.00
Aquestive Therapeutics (AQST) United States $0.106B 0.00
ProNAi Therapeutics (SRRA) Canada $0.103B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 71.11
Zafgen (ZFGN) United States $0.099B 0.00
DURECT (DRRX) United States $0.098B 0.00
Natural Alternatives (NAII) United States $0.097B 9.70
China SXT Pharmaceuticals (SXTC) China $0.093B 0.00
Cardiome Pharma (CORV) Canada $0.092B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
Iterum Therapeutics (ITRM) Ireland $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Infinity Pharmaceuticals (INFI) United States $0.081B 0.00
Neos Therapeutics (NEOS) United States $0.080B 0.00
Avenue Therapeutics (ATXI) United States $0.079B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.078B 0.00
ElectroCore (ECOR) United States $0.075B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.071B 0.00
Capnia (SLNO) United States $0.071B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.067B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
Novan (NOVN) United States $0.059B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.057B 0.00
CTI BioPharma (CTIC) United States $0.049B 0.00
KemPharm (KMPH) United States $0.048B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.043B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Bio-Path Holdings (BPTH) United States $0.041B 0.00
BioLineRx (BLRX) Israel $0.041B 0.00
Lipocine (LPCN) United States $0.039B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
PharmAthene (ALT) United States $0.034B 0.00
ContraFect (CFRX) United States $0.032B 0.00
Melinta Therapeutics (MLNT) United States $0.031B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.028B 0.00
HANCOCK JAFFE (HJLI) United States $0.027B 0.00
Achieve Life Sciences (ACHV) United States $0.027B 0.00
Heat Biologics (HTBX) United States $0.025B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.022B 2.89
Tokai Pharmaceuticals (NVUS) United States $0.021B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
Shineco (TYHT) China $0.016B 2.71
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 3.59
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.007B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00